vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Life360, Inc. (LIF). Click either name above to swap in a different company.
Life360, Inc. is the larger business by last-quarter revenue ($146.0M vs $83.5M, roughly 1.7× BillionToOne, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs 6.8%, a 82.0% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 26.4%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
BLLN vs LIF — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $146.0M |
| Net Profit | $5.7M | $129.7M |
| Gross Margin | 69.9% | 75.1% |
| Operating Margin | 11.5% | 6.1% |
| Net Margin | 6.8% | 88.8% |
| Revenue YoY | 117.4% | 26.4% |
| Net Profit YoY | 138.3% | 1425.9% |
| EPS (diluted) | $0.10 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $146.0M | ||
| Q3 25 | $83.5M | $124.5M | ||
| Q2 25 | — | $115.4M | ||
| Q1 25 | — | $103.6M | ||
| Q4 24 | — | $115.5M | ||
| Q3 24 | $38.4M | $92.9M | ||
| Q2 24 | — | $84.9M | ||
| Q1 24 | — | $78.2M |
| Q4 25 | — | $129.7M | ||
| Q3 25 | $5.7M | $9.8M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $4.4M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | $-14.9M | $7.7M | ||
| Q2 24 | — | $-11.0M | ||
| Q1 24 | — | $-9.8M |
| Q4 25 | — | 75.1% | ||
| Q3 25 | 69.9% | 78.0% | ||
| Q2 25 | — | 78.4% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | 52.6% | 75.4% | ||
| Q2 24 | — | 75.0% | ||
| Q1 24 | — | 76.7% |
| Q4 25 | — | 6.1% | ||
| Q3 25 | 11.5% | 4.6% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 4.9% | ||
| Q3 24 | -32.9% | -5.3% | ||
| Q2 24 | — | -2.8% | ||
| Q1 24 | — | -8.2% |
| Q4 25 | — | 88.8% | ||
| Q3 25 | 6.8% | 7.9% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | -38.8% | 8.3% | ||
| Q2 24 | — | -12.9% | ||
| Q1 24 | — | -12.5% |
| Q4 25 | — | $1.53 | ||
| Q3 25 | $0.10 | $0.11 | ||
| Q2 25 | — | $0.08 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-1.47 | $0.09 | ||
| Q2 24 | — | $-0.15 | ||
| Q1 24 | — | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $494.3M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $548.2M |
| Total Assets | $327.5M | $959.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $494.3M | ||
| Q3 25 | $195.2M | $455.7M | ||
| Q2 25 | — | $432.7M | ||
| Q1 25 | — | $168.9M | ||
| Q4 24 | — | $159.2M | ||
| Q3 24 | — | $159.0M | ||
| Q2 24 | — | $160.8M | ||
| Q1 24 | — | $73.4M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.2M |
| Q4 25 | — | $548.2M | ||
| Q3 25 | $-239.5M | $391.4M | ||
| Q2 25 | — | $366.7M | ||
| Q1 25 | — | $376.3M | ||
| Q4 24 | — | $358.5M | ||
| Q3 24 | $-242.9M | $339.7M | ||
| Q2 24 | — | $326.7M | ||
| Q1 24 | — | $239.8M |
| Q4 25 | — | $959.7M | ||
| Q3 25 | $327.5M | $787.5M | ||
| Q2 25 | — | $753.6M | ||
| Q1 25 | — | $455.4M | ||
| Q4 24 | — | $441.6M | ||
| Q3 24 | — | $427.4M | ||
| Q2 24 | — | $405.9M | ||
| Q1 24 | — | $318.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $36.8M |
| Free Cash FlowOCF − Capex | $6.5M | $36.6M |
| FCF MarginFCF / Revenue | 7.7% | 25.1% |
| Capex IntensityCapex / Revenue | 8.8% | 0.2% |
| Cash ConversionOCF / Net Profit | 2.42× | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $36.8M | ||
| Q3 25 | $13.8M | $26.4M | ||
| Q2 25 | — | $13.3M | ||
| Q1 25 | — | $12.1M | ||
| Q4 24 | — | $12.3M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $3.3M | ||
| Q1 24 | — | $10.7M |
| Q4 25 | — | $36.6M | ||
| Q3 25 | $6.5M | $25.6M | ||
| Q2 25 | — | $12.7M | ||
| Q1 25 | — | $11.9M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | — |
| Q4 25 | — | 25.1% | ||
| Q3 25 | 7.7% | 20.6% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 8.8% | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | 0.28× | ||
| Q3 25 | 2.42× | 2.70× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 2.75× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
LIF
Segment breakdown not available.
